Evidence Hub

Lower respiratory microbiome and metabolome alterations in pediatric ARDS secondary to community-acquired pneumonia

Ying-Chun Wang, Haizhao Zhao, Yuan Ji, Yating Kang, Yun Zhang, Guan Wang, Meng Li

Respiratory Research, 2026

81 participants

Abstract

Pediatric acute respiratory distress syndrome (ARDS) is a severe complication of community-acquired pneumonia (CAP) with high mortality, but the microbial and metabolic mechanisms driving its onset remain unclear. This study aimed to characterize these disturbances and identify potential biomarkers of progression using an integrated multi-omics approach.

We conducted a multi-omics analysis of bronchoalveolar lavage fluid from 81 children with CAP, including those who progressed to ARDS, using 16 S rRNA gene sequencing and untargeted LC-MS/MS metabolomics. Microbial diversity, community composition, metabolic profiles, and functional predictions were compared between groups, and machine learning was applied to identify predictive metabolic signatures. Paired fecal multi-omics data from a subset of patients were analyzed to explore potential gut–lung interactions.

The CAP-ARDS group exhibited significantly reduced microbial α-diversity, as indicated by lower Shannon (

p

= 0.012), Simpson (

p

= 0.015), and Sobs (

p

= 0.046) indices, alongside distinct compositional shifts characterized by

Pseudomonas

enrichment and

Streptococcus

depletion. Metabolomic profiling identified 83 differential metabolites, with pathway topology analysis highlighting perturbations in pantothenate and CoA biosynthesis, indole alkaloid biosynthesis, and steroid degradation. Terpenoid metabolism emerged as a convergent signal across omics layers: PICRUSt2-based prediction revealed increased terpenoid and…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free